4 Deaths Linked to Medical Device; New FDA Chief? Human-Chimp Hybrid Attempt
(MedPage Today) -- Note that some links may require registration or subscription. The FDA warned of a Class I recall of Becton Dickinson intraosseous vascular access system needle sets because of a defect linked to 45 serious injuries and four...
The U.S. Food and Drug Administration (FDA) has issued a Class I recall for Becton Dickinson intraosseous vascular access system needle sets due to a defect linked to 45 serious injuries and four deaths. Meanwhile, the Ebola outbreak in Congo has seen a staggering 5,000 cases, with responders warning of its rapid and unprecedented spread. In the United States, COVID-19 infections are either growing or likely growing in 50 states, as reported by the latest CDC estimates.
The Trump administration is rumored to be appointing White House aide Heidi Overton, MD, PhD, as the next FDA commissioner. Additionally, a novel personalized mRNA-based cancer vaccine, Intismeran autogene, has shown promising results in a phase III trial when added to pembrolizumab (Keytruda). It slowed the return of melanoma and its spread, according to reports from Merck and Moderna.
Research has also suggested that antioxidant-rich diets may lower the risk of cervical cancer, as indicated by survey data. Climate change is raising concerns over heat exposure, with a global modeling study indicating that adults aged 60 and above may face intolerable heat more often and for longer periods than previously thought.
Furthermore, Neutrogena is facing renewed backlash after Hayden Panettiere's unexpected death, with the actress claiming the company had tried to fire her for speaking about postpartum depression.
Written by urgent.news from MedPage Today's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
